Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IMRN

IMRN News

Newswire

16:29

Immuron shares fall 33.77% after-hours as clinical trial for ETEC product fails primary endpoint.

09:35

Immuron shares fall 10.92% intraday amid concerns over high financial risk and unprofitability despite DoD-funded research progress.

04:26

Immuron shares fall 10.97% premarket after announcing 45.47M securities issue to strengthen market position.

06:37

Immuron shares surge 32.76% premarket after securing DoD-funded oral therapeutics development and pending clinical trial results.

06:24

Immuron shares surge 23.56% premarket after U.S. DoD awards therapeutic development and clinical trial updates.

View More

About IMRN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More